Karyopharm Therapeutics Inc.
KPTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001503802
In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 2 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $206.8M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Karyopharm Therapeutics Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −21 vs. Q2 2024
- Shares held
- 59.4M
- −3.98M (−6.3%) vs. Q2 2024
- Total value
- $49.2M
- −$5.79M (−10.5%) vs. Q2 2024
- New holders
- 10
- 21 more added
- Sold out
- 31
- 29 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KPTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $206.8M |
| Q1 2026 | 77 | $98.4M |
| Q4 2025 | 68 | $69.6M |
| Q3 2025 | 52 | $19.5M |
| Q2 2025 | 50 | $19.0M |
| Q1 2025 | 50 | $13.7M |
| Q4 2024 | 87 | $41.2M |
| Q3 2024 | 91 | $49.2M |
| Q2 2024 | 114 | $58.6M |
| Q1 2024 | 114 | $113.0M |
| Q4 2023 | 120 | $63.5M |
| Q3 2023 | 120 | $102.8M |
| Q2 2023 | 138 | $145.0M |
| Q1 2023 | 132 | $340.1M |
| Q4 2022 | 155 | $334.4M |
| Q3 2022 | 147 | $364.1M |
| Q2 2022 | 150 | $302.8M |
| Q1 2022 | 139 | $501.8M |
| Q4 2021 | 143 | $347.5M |
| Q3 2021 | 134 | $334.4M |
| Q2 2021 | 154 | $608.7M |
| Q1 2021 | 171 | $637.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Karyopharm Therapeutics Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −56,945−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −45,930−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −49,160−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −49,160−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −35,939−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −35,184−100.0% | Sold out |
| Redwood Wealth Management Group, LLC | 0 | $0 | 0.00% | −34,030−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −26,798−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −22,951−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −22,562−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −21,941−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −16,431−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −15,435−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −15,170−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −10,950−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −6,248−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −955−100.0% | Sold out |
| Providence Capital Advisors, LLC | 0 | $0 | 0.00% | −312−100.0% | Sold out |
| Kelly Financial Services LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| JJJ Advisors Inc. | – | – | – | – | Not filed |